C12N 2810/6018
Adenoviridae
C12N2810/6018 (Adenoviridae) appears on 87 US grants and 121 published applications in this corpus.
Search patents in C12N- Granted patents
- 87
- Published applications
- 121
- Assignees
- 61
- Inventors
- 216
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 4 | 12 |
| 2003 | 4 | 17 |
| 2004 | 4 | 15 |
| 2005 | 6 | 7 |
| 2006 | 2 | 4 |
| 2007 | 5 | 7 |
| 2008 | 6 | 5 |
| 2009 | 4 | 4 |
| 2010 | 2 | 7 |
| 2011 | 3 | 3 |
| 2012 | 4 | 3 |
| 2013 | 2 | 5 |
| 2014 | 2 | 3 |
| 2015 | 2 | 9 |
| 2016 | 4 | 3 |
| 2017 | 4 | 6 |
| 2018 | 2 | 4 |
| 2019 | 2 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 3 |
| 2023 | 2 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oncolytic tumor viruses and methods of use6 Jan 2026US 12,514,887 B2The Salk Institute for Biological Studies
- Adenoviral vectors27 Aug 2024US 12,071,631 B2Oxford Genetics Limited
- Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof7 Nov 2023US 11,807,866 B2The Trustees of the University of Pennsylvania
- Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration22 Aug 2023US 11,730,781 B2The Salk Institute for Biological Studies
- Modified serotype 28 adenoviral vectors16 Mar 2021US 10,947,560 B2GenVec, Inc.
- Oncolytic Virus and Methods of Use9 May 2024US 2024/0150792 A1
- Recombinant ad35 vectors and related gene therapy improvements18 Aug 2022US 2022/0257796 A1Fred Hutchinson Cancer Research Center
- Oncolytic adenoviral vector expressing a member of the b7 family of costimulatory ligands and ada19 May 2022US 2022/0152134 A1Targovax Asa
- Modulation of rep protein activity in closed-ended dna (cedna) production28 Apr 2022US 2022/0127625 A1Generation Bio Co.
- Modified serotype 28 adenoviral vectors2 Sep 2021US 2021/0269827 A1GenVec, Inc.
Most cited
By later US patents
- Penton base protein and methods of using same136US 5,559,099 AGenVec, Inc. · 1996
- Method for the production and purification of adenoviral vectors110US 6,194,191 B1Introgen Therapeutics, Inc. · 2001
- Adenovirus and methods of use thereof87US 6,001,557 AThe Trustees of the University of Pennsylvania · 1999
- Vectors and methods for gene transfer to cells80US 5,965,541 AGenVec, Inc. · 1999
- Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses71US 7,291,498 B2The Trustees of the University of Pennsylvania · 2007